Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Botulism Antitoxin Effects on Paralysis Induced by Type A and Type B Botulinum Neurotoxins in the Extensor Digitorum Brevis Muscle

NCT00636519 is registered in ClinicalTrials.gov with Emergent BioSolutions as lead sponsor.

NCT NCT00636519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00636519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Botulism Antitoxin Effects on Paralysis Induced by Type A and Type B Botulinum Neurotoxins in the Extensor Digitorum Brevis Muscle
Lead sponsor
Emergent BioSolutions
Phase
Phase 1
Overall status
Completed
Start date
February 29, 2008
Completion date
October 31, 2009
Enrollment
36 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers